Mirum Pharmaceuticals Inc...

NASDAQ: MIRM · Real-Time Price · USD
67.89
3.06 (4.72%)
At close: Aug 15, 2025, 3:59 PM
67.86
-0.04%
After-hours: Aug 15, 2025, 06:59 PM EDT

Mirum Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-87.94M -163.41M -135.66M -83.99M
Depreciation & Amortization
23.63M 10.83M 3.68M 975K
Stock-Based Compensation
48.44M 35.02M 27.01M 23.09M
Other Working Capital
-3.13M -5.05M -4.51M -5.18M
Other Non-Cash Items
3.6M 69.26M 12.47M -90.41M
Deferred Income Tax
n/a n/a -6.58M 595K
Change in Working Capital
22.59M -22.64M -21.05M 16.98M
Operating Cash Flow
10.32M -70.94M -120.14M -132.76M
Capital Expenditures
-993K -20.11M -278K -19.02M
Cash Acquisitions
n/a -212.76M -7.98M -19M
Purchase of Investments
-89.03M -27.33M -132.32M -198.03M
Sales Maturities Of Investments
19.89M 153M 140.3M 157.6M
Other Investing Acitivies
-20M -20M 7.98M 127M
Investing Cash Flow
-90.13M -107.2M 7.7M 48.55M
Debt Repayment
n/a 305.3M n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
17.7M -185.39M 1.72M 66.55M
Financial Cash Flow
17.7M 336.6M 109.09M 73.47M
Net Cash Flow
-63.4M 158.32M -3.34M -10.75M
Free Cash Flow
9.33M -91.05M -120.41M -151.78M